Page 6 - Industry Classification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hong Kong stock market finished session lower on Wednesday, 02 June 2021, as investors booked profit after hitting a three-month high yesterday on healthy two-day run-up, with technology and healthcare stocks being notable losers At closing bell, the benchmark Hang Seng Index declined 0.58%, or 170.38 points, to 29,297.62. The benchmark on Tuesday reached the highest level since March 3. The Hang Seng China Enterprises Index dropped 0.35%, or 38.91 points, to 10,951.84. The sub-index of the Hang Seng tracking the commerce & industry sector fell 0.52% and the finance sector fell 0.82%, while ...

In this article we discuss the 10 best tech ETFs to buy according to Reddit. If you want to skip our detailed analysis of these ETFs, go directly to the...

Manchester & London Investment Trust Plc - Half-year Report PR Newswire (the "Company") Half-yearly report for the six months ended 31 January 2021 A copy of the Half-Yearly Report can be accessed via the Company's website at www.mlcapman.com/manchester-london-investment-trust-plc or by contacting the Company Secretary by telephone on 01392 477500. Summary of Results 256,791 633.62 11.8% Six months to 7.00 Ex-dividend date During the half year under review, the total NAV per Share return was 2.4 per cent, compared to an increase in the benchmark of 11.8 per cent. It has been a period where ...

Dreamstime Biotech companies have been riding the wave of Covid-19 vaccine excitement for months now, as the pandemic reignited investors’ confidence in the value of their research, technology, and platforms. Leaders in coronavirus vaccine development like Moderna (ticker: MRNA) and Novavax (NVAX) have seen their stocks surge wildly, but the rally isn’t limited to them. The biggest winners in 2020 also included firms with breakthroughs in other areas, such as Twist Bioscience (TWST), which developed a DNA synthesis platform that made Covid testing poss...

Avadel Pharmaceuticals Added to NASDAQ Biotechnology Index Avadel Pharmaceuticals Added to NASDAQ Biotechnology Index DUBLIN, Ireland, Dec. 15, 2020 — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 21, 2020. The NASDAQ Biotechnology Index is designed t...